Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.62% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
TELA · Mar 31, 2026
TELA Bio, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001104659-26-060234General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-58.61% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
2.91% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
64.08% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
65.69% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-55.23% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
12.29% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
4.28% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History13 statesHistory building
Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20240/9 normalizedLevel 3Dec 31, 20240/9 normalizedLevel 3Mar 31, 20250/9 normalizedLevel 3Jun 30, 20258/9 normalizedLevel 3Sep 30, 20257/8 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 0.56%
- Current
- 0.62%
- Delta
- 0.07%
- Previous
- -35.15%
- Current
- -58.61%
- Delta
- -23.45%
- Previous
- 15.84%
- Current
- 2.91%
- Delta
- -12.93%
- Previous
- 13.72%
- Current
- 64.08%
- Delta
- 50.36%
- Previous
- 67.69%
- Current
- 65.69%
- Delta
- -2.00%
- Previous
- -42.05%
- Current
- -55.23%
- Delta
- -13.18%
- Previous
- 11.49%
- Current
- 12.29%
- Delta
- 0.81%
- Previous
- 4.73%
- Current
- 4.28%
- Delta
- -0.45%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Has State · TELA Bio, Inc. →Transitioned To · TELA Fundamental State →Transitioned To · TELA CAPEX_INTENSITY_INCREASED →Transitioned To · TELA CASH_GENERATION_DECREASED →Transitioned To · TELA GROWTH_DECREASED →Transitioned To · TELA INVENTORY_PRESSURE_INCREASED →Transitioned To · TELA MARGIN_DECREASED →Transitioned To · TELA PROFITABILITY_DECREASED →Transitioned To · TELA R_AND_D_INTENSITY_INCREASED →Transitioned To · TELA SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.